BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19731827)

  • 1. [The clinical and pathological subtypes of Castleman's disease and their relationship with complications: a large series analysis from a single center].
    Dong YJ; Wang RG; Chen XX; Na J; Lu JC; Li N; Xu WL; Ren HY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):255-9. PubMed ID: 19731827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor.
    Dong Y; Wang M; Nong L; Wang L; Cen X; Liu W; Zhu S; Sun Y; Liang Z; Li Y; Ou J; Qiu Z; Ren H
    Br J Haematol; 2015 Jun; 169(6):834-42. PubMed ID: 25824806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment and prognosis analysis of localized retroperitoneal Castleman disease: a study of 20 cases].
    Tang JQ; Yang YM; Xiong Y; Wan YL; Zhu XJ
    Zhonghua Wai Ke Za Zhi; 2009 Nov; 47(22):1685-8. PubMed ID: 20137716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of interleukin-6 and its clinicopathological significance in Castleman's disease].
    Lai YM; Li M; Liu CL; Huang X; Yu GH; Wang XY; Sun L; Chen J; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):404-8. PubMed ID: 23688750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center.
    Dong Y; Na J; Lv J; Wang R; Chen X; Li N; Ren H
    Leuk Lymphoma; 2009 Aug; 50(8):1308-17. PubMed ID: 19579073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and surgical treatment of Castleman's disease].
    Ma SH; Liu QJ; Zhang YC; Yang R
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1118-21. PubMed ID: 21609596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of paraneoplastic pemphigus with Castleman's disease].
    Wu WH; Yang YM; Zhu XJ; Wang RG; Chen JH; Huang YT
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(14):849-52. PubMed ID: 15363272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant Stroma-Rich Feature in Hyaline Vascular Variant of Castleman Disease Is Associated With Paraneoplastic Pemphigus.
    Wang L; Nong L; Li F; Wang X; Wang R; Chen X; Tu P; Dong Y; Li T; Zhu X; Wang M
    Am J Clin Pathol; 2020 Aug; 154(3):403-413. PubMed ID: 32459333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and surgical treatment of thoracic Castleman's disease].
    Wang XX; Liu TL; Jiao WJ
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):96-8. PubMed ID: 20302725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of plasma cell type of Castleman's disease and IgG4-related sclerosing disease: a histopathological and immunohistochemical study.
    Jo JH; Park YS; Jeon YK; Nam SJ; Huh J
    Pathobiology; 2011; 78(4):227-32. PubMed ID: 21778790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and prognosis in 49 patients with Castleman's disease].
    Yu GP; Wang SJ; Shi J; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):570-4. PubMed ID: 19968073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical data analysis on 43 cases of the giant lymph node hyperplasia].
    Ye B; Li W; Yang LH; Ma K; Liu XY; Sun KL
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1334-6. PubMed ID: 19615188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Analysis of Unicentric Castleman's Disease with Paraneoplastic Pemphigus and Bronchiolitis Obliterans.
    Zhen JF; Zhang L; Cao XX; Feng J; Zhou DB; Lin SB; Li J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):492-498. PubMed ID: 28877826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis on giant lymph node hyperplasia on neck].
    Ma SH; Liu QJ; Wang J; Yang R
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):223-6. PubMed ID: 19558862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Localized Castleman disease with paraneoplastic pemphigus and pulmonary involvement: clinical features and histopathology].
    Sun H; Wang R; Bin H; Na J; Li L; Wang Y; Jiang X; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):530-3. PubMed ID: 12133498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinicopathological study of Castleman's disease].
    Na J; Liu P; Wang RG; Wang LC; Zou WZ
    Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):521-4. PubMed ID: 14761596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a paraneoplastic pemphigus in a teenager using plasmapheresis, corticosteroids and tumour resection.
    Jing L; Shan Z; Yongchu H; Xixue C; Xuejun Z
    Clin Exp Dermatol; 2011 Oct; 36(7):752-4. PubMed ID: 21933232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of 5 children with Castleman's disease and review of literature].
    Huang S; Zhou CJ; Jin M; Jin L; Zhang R; Zhang YH
    Zhonghua Er Ke Za Zhi; 2010 Aug; 48(8):625-8. PubMed ID: 21055311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical spectrum and survival analysis of 145 cases of HIV-negative Castleman's disease: renal function is an important prognostic factor.
    Zhang L; Li Z; Cao X; Feng J; Zhong D; Wang S; Zhou D; Li J
    Sci Rep; 2016 Mar; 6():23831. PubMed ID: 27029894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent corneal melting in the paraneoplastic pemphigus associated with Castleman's disease.
    Gong H; Zhou S; Hu Y; Lan Y; Zeng H; Wang L; Liu Q; Wang M
    BMC Ophthalmol; 2016 Jul; 16():106. PubMed ID: 27406120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.